Australian University Rankings Guide

International Journal of Peptide Research and Therapeutics (ERA Journal)

International Journal of Peptide Research and Therapeutics is an ERA accredited research journal used as part of the evaluation of the ERA research rankings.

International Journal of Peptide Research and Therapeutics issns are issn1: 0929-5666 issn2: 1573-3149 issn3: 1573-3904.

The fields covered by International Journal of Peptide Research and Therapeutics as part of the evaluation of Australian university research excellence are:

Biochemistry and Cell Biology Research Rankings (Sub-Field)

Medical Biochemistry and Metabolomics Research Rankings (Sub-Field)

Other ERA-accredited journals supporting the evaluation of the Biochemistry and Cell Biology field include:

- Antioxidants and Redox Signaling
- Cell Biology and Toxicology: an international journal devoted to research at the cellular level
- Cellular and Molecular Life Sciences
- Chemistry and Biology
- Essays in Biochemistry
- Imia Yearbook
- International Journal of Biomedical Science
- Journal of Biorepository Science for Applied Medicine
- Journal of Molecular Biology
- Journal of Molecular Evolution
- Journal of Molecular Histology
- Journal of Trace Elements in Medicine and Biology
- Molecular Biology and Evolution
- Photosynthesis Research
- Wiley Interdisciplinary Reviews: Developmental Biology


ERA Research Rankings Submenu


- ERA 2018 Outcomes Research Rankings List

- ERA 2018 Research Rankings Analysis

- ERA 2018 Individual University Outcomes List

- ERA List of Research Fields Rankings

- ERA Journal Rankings 2018 List



Latest News and Updates:


- Top 10 Best Australian Universities

- Gender Balance Male-Female Ratio

- ERA 2018 Outcomes Research Rankings List

- University Bachelor Degree Completion Rates

- QS Employability Rankings Australian Universities

- ARWU World Rankings of Australian Universities

- Group of Eight (go8) World Rankings

Share This Page

  • Share on Facebook1
  • Share on Twitter2
  • Share on Linkedin3
  • Share on Reddit4